An Update on the Use of Sedative-Hypnotic Medications in Psychiatric Disorders
- PMID: 27417512
- PMCID: PMC4980146
- DOI: 10.1007/s11920-016-0717-y
An Update on the Use of Sedative-Hypnotic Medications in Psychiatric Disorders
Abstract
Sleep disturbance is a common clinical problem experienced by patients with a wide range of psychiatric disorders. Accumulating evidence has demonstrated that insomnia is a comorbid process that affects the course and treatment of a number of forms of mental illness. The efficacy and safety of sedative-hypnotic medications have largely been established in patients who do not have comorbid psychiatric disorders, underscoring the need for further research in this sphere. This review summarizes pertinent findings in the recent literature that have examined the role of hypnotic medication in the treatment of psychiatric illness, and highlights potential areas that may prove fruitful avenues of future research.
Keywords: Hypnotic; Insomnia; Psychiatric; Sedative; Sleep.
Conflict of interest statement
Conflict of Interest:
Dr. Creado Reports no conflicts of interest.
Similar articles
-
Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.J Clin Sleep Med. 2015 Apr 15;11(5):543-51. doi: 10.5664/jcsm.4700. J Clin Sleep Med. 2015. PMID: 25766696 Free PMC article.
-
[Clinical Problems before Initiating Pharmacotherapy for Insomnia].Seishin Shinkeigaku Zasshi. 2015;117(4):277-82. Seishin Shinkeigaku Zasshi. 2015. PMID: 26524839 Review. Japanese.
-
Effectiveness of a CBT Intervention for Persistent Insomnia and Hypnotic Dependency in an Outpatient Psychiatry Clinic.J Clin Psychol. 2015 Jul;71(7):666-83. doi: 10.1002/jclp.22186. Epub 2015 Apr 23. J Clin Psychol. 2015. PMID: 25907406 Clinical Trial.
-
A psychiatric perspective on insomnia.J Clin Psychiatry. 2001;62 Suppl 10:27-32. J Clin Psychiatry. 2001. PMID: 11388587 Review.
-
Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.J Clin Psychiatry. 1994 Feb;55(2):60-5. J Clin Psychiatry. 1994. PMID: 7915708 Clinical Trial.
Cited by
-
A pragmatic effectiveness randomized controlled trial of the duration of psychiatric hospitalization in a trans-diagnostic sample of patients with acute mental illness admitted to a ward with either blue-depleted evening lighting or normal lighting conditions.Trials. 2019 Aug 1;20(1):472. doi: 10.1186/s13063-019-3582-2. Trials. 2019. PMID: 31370871 Free PMC article.
-
Associations between daily affect and sleep vary by sleep assessment type: What can ambulatory EEG add to the picture?Sleep Health. 2021 Apr;7(2):219-228. doi: 10.1016/j.sleh.2020.11.009. Epub 2021 Jan 14. Sleep Health. 2021. PMID: 33454245 Free PMC article.
-
Utilization of potentially inappropriate sedative-hypnotic and atypical antipsychotic medications among elderly individuals with insomnia and Alzheimer's disease.Sleep. 2025 Apr 11;48(4):zsaf003. doi: 10.1093/sleep/zsaf003. Sleep. 2025. PMID: 39862174 Free PMC article.
-
Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database.BMC Psychiatry. 2023 Apr 20;23(1):278. doi: 10.1186/s12888-023-04683-2. BMC Psychiatry. 2023. PMID: 37081408 Free PMC article.
-
Chronic hypnotic use at 10 years-does the brand matter?Eur J Clin Pharmacol. 2018 Dec;74(12):1623-1631. doi: 10.1007/s00228-018-2531-4. Epub 2018 Aug 8. Eur J Clin Pharmacol. 2018. PMID: 30090968
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth. Arlington, VA: American Psychiatric Association; 2013.
-
- American Academy of Sleep Medicine. International Classification of Sleep Disorders. Third. Darien, IL: American Academy of Sleep Medicine; 2014.
-
- Wu JQ, Appleman ER, Salazar RD, Ong JC. Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis. JAMA Intern Med. 2015;175(9):1461–1472. - PubMed
-
- Quera-Salva MA, Lemoine P, Guilleminault C. Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients. Hum Psychopharmacol. 2010;25(3):222–229. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical